U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from MedGen

Items: 1 to 20 of 148

1.
Tissue factor targeted near-infrared photoimmunotherapy: a versatile therapeutic approach for malignancies
Seiichiro Takao, Hiroshi Fukushima, Aki Furusawa, Takuya Kato, Shuhei Okuyama, Makoto Kano, Hiroshi Yamamoto, Motofumi Suzuki, Miyu Kano, Peter L. Choyke, Hisataka Kobayashi
Cancer Immunol Immunother. 2025 Feb; 74(2): 48. Published online 2025 Jan 3. doi: 10.1007/s00262-024-03903-2
PMCID:
PMC11699179
AbstractArticlePDF–6.5M
2.
Squamous Cell Carcinoma of the Ovary: A Rare Case
Chrysoula Margioula-Siarkou, Emmanouela-Aliki Almperi, Aristarchos Almperis, Georgia Margioula-Siarkou, Georgios Titilas, Konstantinos Dinas, Stamatios Petousis
Cureus. 2024 Nov; 16(11): e74547. Published online 2024 Nov 26. doi: 10.7759/cureus.74547
PMCID:
PMC11671788
AbstractArticlePDF–779K
3.
Comprehensive analysis of PDE2A: a novel biomarker for prognostic value and immunotherapeutic potential in human cancers
Zhen Yu, Yawen Song, Jin Wang, Yujing Wu, Hefang Wang, Shuye Liu, Yu Zhu
Braz J Med Biol Res. 2024; 57: e14220. Published online 2024 Dec 13. doi: 10.1590/1414-431X2024e14220
PMCID:
PMC11653488
AbstractArticlePDF–3.0M
4.
Comprehensive pan-cancer analysis of CD73: Explore its association with prognosis and tumor immune microenvironment
Chen Chen, Sasa Liu, Yanfen Ma
Heliyon. 2024 Nov 30; 10(22): e40329. Published online 2024 Nov 12. doi: 10.1016/j.heliyon.2024.e40329
PMCID:
PMC11609644
AbstractArticlePDF–10M
5.
Tumor-infiltrating B cell-related lncRNA crosstalk reveals clinical outcomes and tumor immune microenvironment in ovarian cancer based on single-cell and bulk RNA-sequencing
Yi Huang, Zhongxuan Gui, Muyun Wu, Mengmeng Zhang, Yue Jiang, Qiaoqiao Ding, Jinping Yang, Yingquan Ye, Mei Zhang
Heliyon. 2024 Nov 15; 10(21): e39496. Published online 2024 Oct 18. doi: 10.1016/j.heliyon.2024.e39496
PMCID:
PMC11570495
AbstractArticlePDF–15M
6.
Unveiling the Uncommon: Ovarian Cancer Metastasis as a Rare Cause of Obstructive Jaundice and Partial Gastric Outlet Obstruction
Pragna Puvvada, Pushkar Galam, Vaishnavi Reddy, Romi H Gaudani, Pravin S Mane
Cureus. 2024 Oct; 16(10): e71312. Published online 2024 Oct 12. doi: 10.7759/cureus.71312
PMCID:
PMC11554442
AbstractArticlePDF–4.4M
7.
Comprehensive Pan-Cancer Analysis of the Prognostic Role of KLF Transcription Factor 2 (KLF2) in Human Tumors
Rong Xu, Yuhan Chen, Shicai Wei, Jun Chen
Onco Targets Ther. 2024; 17: 887–904. Published online 2024 Nov 2. doi: 10.2147/OTT.S476179
PMCID:
PMC11539754
AbstractArticlePDF–15M
8.
High Expression of TBC1 Domain Family Member 22A is Related to Poor Prognosis in Ovarian Serous Cystadenocarcinoma
Xiaofeng Lv, Ruyue Gong, Lili Guo, Changyu Wang
Int J Med Sci. 2024; 21(13): 2603–2612. Published online 2024 Oct 7. doi: 10.7150/ijms.99744
PMCID:
PMC11492882
AbstractArticlePDF–5.7M
9.
Scinderin is a potential prognostic biomarker and correlated with immunological regulation: from pan-cancer analysis to liver hepatocellular carcinoma
Shengyong Zhai, Yuhua Li, Yuanyuan Yang, Wei Lang, Xiaoxia Liu, Kai Liu, Jianjun Qu, Lingyu Zhu
Front Immunol. 2024; 15: 1361657. Published online 2024 Jul 23. doi: 10.3389/fimmu.2024.1361657
PMCID:
PMC11300247
AbstractArticlePDF–11M
10.
Pan‑cancer analysis on the role of KMT2C expression in tumor progression and immunotherapy 
Wei Cao, Yawen Xie, Li Cai, Mengqing Wang, Zhuoying Chen, Ziteng Wang, Jiajia Xv, Yuqing Wang, Rong Li, Xuesong Liu, Wenliang Wang
Oncol Lett. 2024 Sep; 28(3): 444. Published online 2024 Jul 19. doi: 10.3892/ol.2024.14577
PMCID:
PMC11292467
AbstractArticlePDF–3.9M
11.
Unique immune characteristics and differential anti-PD-1-mediated reinvigoration potential of CD8+ TILs based on BRCA1/2 mutation status in epithelial ovarian cancers
Junsik Park, Jung Chul Kim, Yong Jae Lee, Sunghoon Kim, Sang Wun Kim, Eui-Cheol Shin, Jung Yun Lee, Su-Hyung Park
J Immunother Cancer. 2024; 12(7): e009058. Published online 2024 Jul 4. doi: 10.1136/jitc-2024-009058
PMCID:
PMC11227838
AbstractArticlePDF–3.1M
12.
The intratumoral microbiota biomarkers for predicting survival and efficacy of immunotherapy in patients with ovarian serous cystadenocarcinoma
Hao Qin, Jie Liu, Yi Qu, Yang-Yang Li, Ya-Lan Xu, Yi-Fang Yan
J Ovarian Res. 2024; 17: 140. Published online 2024 Jul 5. doi: 10.1186/s13048-024-01464-7
PMCID:
PMC11227176
AbstractArticlePDF–7.8M
13.
Identification of the biological functions and chemo-therapeutic responses of ITGB superfamily in ovarian cancer
Jiawen Han, Lin Lyu
Discov Oncol. 2024 Dec; 15: 198. Published online 2024 May 30. doi: 10.1007/s12672-024-01047-4
PMCID:
PMC11139846
AbstractArticlePDF–11M
14.
Folate receptor alpha protein expression in ovarian serous cystadenocarcinoma tumors of The Cancer Genome Atlas: exploration beyond single-agent therapy
Christianne Persenaire, Benjamin G. Bitler, Bradley R. Corr
Version 1. medRxiv. Preprint. 2024 Apr 14. doi: 10.1101/2024.04.12.24305742
PMCID:
PMC11030472
AbstractArticlePDF–525K
15.
NF2 is a candidate diagnosis, prognostic, and immunotherapeutic biomarker: a systematic pan-cancer analysis
Honglu Zhang, Jiyong Liu
Transl Cancer Res. 2024 Feb 29; 13(2): 1026–1042. Published online 2024 Feb 1. doi: 10.21037/tcr-23-1179
PMCID:
PMC10928596
AbstractArticlePDF–5.6M
16.
Significant Prognostic Factor at Age Cut-off of 73 Years for Advanced Ovarian Serous Cystadenocarcinoma Patients: Insights from Real-World Study
Ke Zhang, Songwei Feng, Yan Wang, Wen Feng, Yang Shen
Int J Womens Health. 2024; 16: 203–218. Published online 2024 Feb 3. doi: 10.2147/IJWH.S439335
PMCID:
PMC10849902
AbstractArticlePDF–7.8M
17.
Comprehensive analysis and immunohistochemistry localization of NRP1 expression in pancancer and normal individual tissues in relation to SARS‑CoV‑2 susceptibility
Jiewen Fu, Jiayue He, Lianmei Zhang, Jingliang Cheng, Pengfei Zhang, Chunli Wei, Junjiang Fu, Dabing Li
Exp Ther Med. 2024 Feb; 27(2): 52. Published online 2023 Dec 5. doi: 10.3892/etm.2023.12340
PMCID:
PMC10790162
AbstractArticlePDF–6.5M
18.
ANGPTL4 accelerates ovarian serous cystadenocarcinoma carcinogenesis and angiogenesis in the tumor microenvironment by activating the JAK2/STAT3 pathway and interacting with ESM1
Yu-kun Li, An-bo Gao, Tian Zeng, Dan Liu, Qun-feng Zhang, Xiao-min Ran, Zhen-zi Tang, Yan Li, Jue Liu, Ting Zhang, Gang-qing Shi, Wen-chao Zhou, Wen-da Zou, Juan Peng, Juan Zhang, Hui Li, Juan Zou
J Transl Med. 2024; 22: 46. Published online 2024 Jan 11. doi: 10.1186/s12967-023-04819-8
PMCID:
PMC10785435
AbstractArticlePDF–14M
19.
Comprehensive analysis of the potential biological significance of cuproptosis-related gene LIPT2 in pan-cancer prognosis and immunotherapy
Wangbiao Wang, Shiang Li, Yumian Huang, Jun Guo, Lili Sun, Gang Sun
Sci Rep. 2023; 13: 22910. Published online 2023 Dec 21. doi: 10.1038/s41598-023-50039-x
PMCID:
PMC10739704
AbstractArticlePDF–9.6M
20.
Abnormal expressions of PURPL, miR-363-3p and ADAM10 predicted poor prognosis for patients with ovarian serous cystadenocarcinoma
Ruitao Zhang, Xueying Guo, Limin Zhao, Tingting He, Wei Feng, Shumin Ren
J Cancer. 2023; 14(15): 2908–2918. Published online 2023 Sep 11. doi: 10.7150/jca.87405
PMCID:
PMC10539555
AbstractArticlePDF–4.9M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center